AAV8-DX88-HSA

N/A

Report date: 2025/05/27 10:27:44

Base Information

Drug NameAAV8-DX88-HSA
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionPlasma kallikrein modulators
TargetsPlasma kallikrein
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A